Leveraging Smart Engineering for Sophisticated Bi- & Multispecific Molecular Design with Improved Specificity, Expanded Therapeutic Windows & Optimized Developability to Achieve Clinical Validation & Derisk CMC
The bispecific, multispecific and cell engager space is entering a new era of clinical validation and rapid innovation, as next-generation formats and sophisticated molecular architectures move closer to patients. Following a year marked by landmark clinical readouts for BiTEs and major acquisitions in the VEGF/PD1 space, 2026 will define the next wave of differentiated bispecifics across oncology, immunology and beyond.
The 17th World Bispecific Summit US returns as the definitive forum for navigating this complexity, bringing together leaders in antibody discovery, protein engineering, translational science and early clinical development to accelerate highly innovative multi-target therapeutics with optimized specificity, developability and therapeutic windows.
Unlike broader antibody or protein engineering meetings, this highly focused community connects the full drug development value chain, from early discovery through to preclinical and clinical development, ensuring discussions are practical, technical and directly relevant to pipeline progression.
As competitive pressure intensifies and biologics lose exclusivity, there has never been a more critical moment to refine your strategy, validate next-gen formats, and position your bispecific, multispecific and cell engager programs for clinical success. Join the experts shaping the future of bispecifics from the likes of AstraZeneca, Pfizer, Merck, Amgen and more as this drug modality demonstrates superior specificity, safety, efficacy and differentiation, and caters to patients with unmet need.
The World Bispecific Summit is an ideal forum to hear from cutting edge experts, connect with stakeholders spanning molecule design to translation, and explore the next sets of challenges facing the field.
Jay Fine, President, Research & Development, EvolveImmune Therapeutics
The meeting offers direct exposure to industry leaders and KOLs from pharma and biotech. Attend if you want a practical, scientifically dense meeting on how to design, de-risk and clinically validate next generation bi/multi-specific therapeutics.
Agnish Dey, Senior Scientist, Takeda Pharmaceuticals
This conference provides the opportunity to see cutting edge developments in the field of bispecific antibodies. The intimate nature of the conference facilitates connections and ad hoc conversations with peers that can be difficult to find at larger events.
Jared Shadish, Senior Scientist, AstraZeneca
Explore the Full World Bispecific Summit Agenda
- Get a full overview of the bispecific agenda, expert speaker faculty, and deep-dive seminar day
- Preview cutting-edge case studies spanning co-stimulation, masking and conditional activation approaches to complex formats
- Explore exclusive content including panels on industry trends, innovation showcases, and practical insights into next-generation bispecific design
- Easily share with colleagues and decision-makers evaluating partners, platforms, and strategies in the bispecific space
2025 Speakers
Official Partners
Lead Partner
Expertise Partners
Hosting Partner
Innovation Partner
Exhibition Partners
Event Partners
Explore the Agenda
Uncover the latest advances in bispecific development, from novel PD-1/VEGF breakthroughs to emerging autoimmune applications. Gain exclusive insights into target selection, translational hurdles, and clinical strategy through expert-led panels and interactive roundtable discussions.
Partner With Us
Align your brand with industry leaders driving the future of Bispecifics. Showcase your expertise and connect with senior decision-makers actively seeking innovative discovery, development, and manufacturing solutions.
Join Biopharma Experts
Engage in high-impact discussions with peers across discovery, preclinical, translational, and clinical development. Build meaningful relationships and explore strategic opportunities through structured and informal networking sessions.